What Researchers Did
Researchers conducted a narrative review of 23 studies to summarize medical, endoscopic, and surgical treatment options for rectal cuffitis in IBD patients with an ileal pouch-anal anastomosis.
What They Found
The review found that mesalamine and corticosteroid regimens, investigated in 16 studies with 4-120 patients, were the most common medical interventions, showing symptomatic improvement in 52-100% of patients and decreases of 1.14-1.8 points in endoscopic disease activity indices. Advanced therapies like ustekinumab and vedolizumab were explored in smaller studies (1-21 patients) with variable responses, while seven studies examined endoscopic and surgical approaches.
What This Means for Canadian Patients
Canadian patients with rectal cuffitis following ileal pouch-anal anastomosis have several treatment options, typically starting with mesalamine suppositories or corticosteroids. For those with refractory cuffitis, advanced therapies or surgical interventions may be considered to manage their symptoms and inflammation.
Canadian Relevance
This narrative review did not include any specific Canadian studies or data.
Study Limitations
As a narrative review, this study may be subject to selection bias, and many advanced therapy studies included had small sample sizes and variable responses.